RBC Capital lowered the firm’s price target on Acadia Healthcare (ACHC) to $22 from $28 and keeps an Outperform rating on the shares, updating the firm’s model after the company’s Q3 results last week. Weaker Medicaid volume and increased bad debt expense was the primary driver of the company’s weaker performance and revised 2025 outlook, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare Settles $179M Securities Litigation
- Acadia Healthcare price target lowered to $27 from $29 at Guggenheim
- Acadia Healthcare’s Earnings Call: Mixed Sentiments and Strategic Moves
- Optimistic Buy Rating for Acadia Healthcare Amid Strategic Growth Initiatives
- Acadia Healthcare price target lowered to $22 from $25 at Cantor Fitzgerald